Glaucoma in rural China (the Rural Epidemiology for Glaucoma in China (REG-China)): a national cross-sectional study.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
10 2023
Historique:
received: 09 11 2021
accepted: 29 06 2022
medline: 25 9 2023
pubmed: 16 7 2022
entrez: 15 7 2022
Statut: ppublish

Résumé

This study aimed to investigate the prevalence of glaucoma with associated factors in the rural populations of 10 provinces in China. A population-based cross-sectional study. All participants aged 6 years or older from 10 provinces completed visual acuity testing, slit-lamp examination, ophthalmoscopy and non-contact tonometry. Glaucoma suspects underwent fundus photography, Goldmann applanation tonometry, visual field testing and gonioscopy. Glaucoma was determined according to the International Society of Geographical and Epidemiological Ophthalmology classification scheme. Associations of demographics and medical factors with glaucoma were assessed using multiple logistic regression models. From June 2017 to October 2018, 48 398 of 52 041 participants were included in the final analyses. The age-standardised prevalence of glaucoma was 1.7% (95% CI 1.55% to 1.78%) among the participants older than 6 years, which was 2.1% (95% CI 1.93% to 2.23%) in participants aged over 40 years. The constituent ratios of glaucoma were: 44.4% primary angle-closure glaucoma (PACG), 34.7% primary open-angle glaucoma, 2.6% congenital glaucoma and 18.3% other types of glaucoma. Increasing age, smoking, cerebral stroke, type 2 diabetes, higher education (college or more) and higher personal income were significant risk factors for PACG. The unilateral and bilateral blindness rates in the entire study population were 4.692% and 1.068%, respectively. A family history of glaucoma was a significant risk factor for the prevalence of glaucoma and blindness in at least one eye. Rural populations have a high prevalence of glaucoma, which should be included in chronic disease management programmes in China for long-term care.

Identifiants

pubmed: 35840290
pii: bjo-2021-320754
doi: 10.1136/bjo-2021-320754
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1458-1466

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Yuanyuan Liu (Y)

Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China.

Baoqun Yao (B)

Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China.

Xi Chen (X)

Department of Occupational and Environmental Health, School of Public Health, Tianjin Key Laboratory of Environment, Nutrition, and Public Health, Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin Medical University, Tianjin, China.

Xueli Yang (X)

Department of Occupational and Environmental Health, School of Public Health, Tianjin Key Laboratory of Environment, Nutrition, and Public Health, Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin Medical University, Tianjin, China.

Yong Liu (Y)

Department of Ophthalmology, Southwest Hospital/Southwest Eye Hospital, Army Medical University, Chongqing, China.

Zhenggao Xie (Z)

Department of Ophthalmology, Subei People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, China.

Xiaofeng Chen (X)

Department of Ophthalmology, Ineye Hospital of Chengdu University of TCM, Chengdu, Sichuan, China.

Zhigang Yuan (Z)

Department of Ophthalmology, Shanxi Eye Hospital, Taiyuan, Shanxi, China.

Xingrong Wang (X)

Department of Ophthalmology, Eye Institute of Shandong University of Traditional Chinese Medicine, Affiliated Eye Hospital of Shandong University of TCM, Jinan, Shandong, China.

Dan Hu (D)

Department of Ophthalmology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.

Xiang Ma (X)

Department of Ophthalmology, Guyuan Municipal People's Hospital, Guyuan, Gansu, China.

Weiqi Gao (W)

Department of Ophthalmology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Ruifeng Wang (R)

Department of Ophthalmology, Zhengzhou Second People's Hospital, Zhengzhou, Henan, China.

Yuzhong Yang (Y)

Department of Ophthalmology, Beizhen People's Hospital, Jinzhou, Liaoning, China.

Song Chen (S)

Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China.

Jingkai Zhang (J)

Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China.

Zuoqing Song (Z)

Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.

Junsu Wang (J)

Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China.

Jing Wang (J)

Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.

Jinyun Pei (J)

Department of Ophthalmology, Santan Hospital, Tianjin, China.

Weijuan Wang (W)

Department of Ophthalmology, Binhai Hospital of Tianjin Medical University General Hospital, Tianjin, China.

Meiyan Wang (M)

Department of Ophthalmology, Tianjin Haibin People's Hospital, Tianjin, China.

Jun Gao (J)

Department of Ophthalmology, Tianjin Third Central Hospital, Tianjin, China.

Hongwen Zhang (H)

Department of Ophthalmology, Tianjin Jizhou District People's Hospital, Tianjin, China.

Lian Tan (L)

Department of Ophthalmology, Southwest Hospital/Southwest Eye Hospital, Army Medical University, Chongqing, China.

Wei Du (W)

Department of Ophthalmology, Subei People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, China.

Xuehui Pan (X)

Department of Ophthalmology, Ineye Hospital of Chengdu University of TCM, Chengdu, Sichuan, China.

Gang Liu (G)

Department of Ophthalmology, Shanxi Eye Hospital, Taiyuan, Shanxi, China.

Xiujuan Du (X)

Department of Ophthalmology, Eye Institute of Shandong University of Traditional Chinese Medicine, Affiliated Eye Hospital of Shandong University of TCM, Jinan, Shandong, China.

Xu Hou (X)

Department of Ophthalmology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.

Xin Gao (X)

Department of Ophthalmology, Guyuan Municipal People's Hospital, Guyuan, Gansu, China.

Zhen Zhang (Z)

Department of Ophthalmology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Zhansheng Shen (Z)

Department of Ophthalmology, Zhengzhou Second People's Hospital, Zhengzhou, Henan, China.

Changfu Wu (C)

Department of Ophthalmology, Beizhen People's Hospital, Jinzhou, Liaoning, China.

Xiaochang Yan (X)

National School of Development, Peking University, Beijing, China.

Shaoye Bo (S)

Department of Supervisory Board, China Foundation for Disabled Persons, Beijing, China.

Xinghuai Sun (X)

Department of Ophthalmology and Vision Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.

Nai-Jun Tang (NJ)

Department of Occupational and Environmental Health, School of Public Health, Tianjin Key Laboratory of Environment, Nutrition, and Public Health, Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin Medical University, Tianjin, China.

Chun Zhang (C)

Department of Ophthalmology, Peking University Eye Center, Third Hospital of Peking University, Beijing, China zyyyanhua@tmu.edu.cn zhangc1@yahoo.com.

Hua Yan (H)

Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China zyyyanhua@tmu.edu.cn zhangc1@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH